News - Astex Pharmaceuticals

Filter

Current filters:

Astex Pharmaceuticals

Popular Filters

Astex urges stockholders to tender shares into Otsuka offer

03-10-2013

The board of directors of USA-based Astex Pharmaceuticalsissued a letter to stockholders addressing what…

Astex PharmaceuticalsMergers & AcquisitionsOtsukaPharmaceutical

Otsuka confirms takeover bid for Astex Pharmaceuticals for $886 million

05-09-2013

Following heavy speculation on Wednesday (see The Pharma Letter story earlier today), this morning Japanese…

Astex PharmaceuticalsBiotechnologyMergers & AcquisitionsOncologyOtsukaPharmaceutical

Otsuka said to be buying Astex Pharma

05-09-2013

Japanese mid-size drugmaker Otsuka (TYO: 4768) is planning to acquire USA-based Astex Pharmaceuticals…

Astex PharmaceuticalsBiotechnologyMergers & AcquisitionsOncologyOtsukaPharmaceutical

Astex Pharma shares down after company drops amuvatinib development

25-09-2012

US drug developer Astex Pharmaceuticals (Nasdaq: ASTX) saw its shares fall 8.1% to $3.05 by close last…

amuvatinibAstex PharmaceuticalsBiotechnologyLicensingOncologyPharmaceuticalResearch

US FDA delays Eisai's Dacogen for AML; accepts perampanel NDA

08-03-2012

The US Food and Drug Administration has issued a Complete Response Letter to Japanese drug major Eisai…

Astex PharmaceuticalsDacogenEisaiNeurologicalNorth AmericaOncologyperampanelPharmaceuticalRegulation

FDA wants more info on Menveo; advisory negative on Dacogen

13-02-2012

Swiss drug major Novartis (NOVN: VX) said this morning that it has received a Complete Response letter…

Astex PharmaceuticalsDacogenEisaiMenveoNorth AmericaNovartisOncologyPharmaceuticalRegulationVaccines

Astex to return epigenetics project to GSK

17-01-2012

Astex Pharmaceuticals (Nasdaq: ASTX) says that the multi-year collaboration to discover cancer therapeutics…

Astex PharmaceuticalsGlaxoSmithKlineLicensingOncologyPharmaceuticalSuperGen

Back to top